Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share from the same period last year.